mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0003 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0004 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |